MDXG
MiMedx Group Inc
4.70$
-0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.4% | 70.9% | 65.5% | 40.2% | 60.3% | 60.3% | 79.5% | 79.0% | 78.3% | 68.7% | 72.7% | 81.0% | |
| 42.6% | 21.0% | 17.8% | 22.7% | 36.7% | 36.7% | 47.4% | 46.3% | 38.5% | 34.3% | 39.6% | 48.5% | |
| 47.9% | 23.2% | 17.8% | 22.7% | 36.7% | 36.7% | 47.4% | 46.3% | 38.5% | 34.3% | 39.6% | 48.5% | |
| 24.4% | 39.6% | 34.7% | 0.5% | 0.4% | 0.4% | 17.5% | 21.5% | 25.1% | 22.5% | 21.2% | 22.1% | |
| 4.7% | 5.5% | 9.2% | 7.8% | 13.0% | 13.0% | 5.1% | 6.1% | 7.7% | 8.8% | 9.0% | 7.4% | |
| 5.0% | 7.0% | 7.1% | 11.6% | 14.2% | 12.8% | 5.7% | 7.4% | 6.6% | – | – | – | |
| 3.7% | 3.0% | 10.5% | 16.5% | 16.3% | 16.3% | 9.9% | 10.6% | 11.3% | 8.1% | 7.4% | 5.7% | |
| 9.9% | 7.9% | 12.0% | 8.3% | 7.8% | 7.8% | 3.0% | 2.9% | 3.4% | 2.2% | 4.4% | 4.1% | |
| 18.2% | 20.5% | 31.2% | 39.1% | 59.6% | 59.6% | 54.8% | 50.7% | 56.5% | 40.3% | 26.8% | 25.1% | |
| 16.8% | 19.7% | 26.3% | 37.8% | 58.2% | 58.2% | 29.3% | 22.5% | 25.4% | 19.2% | 17.3% | 18.8% | |
| – | – | 0.0% | – | – | 3.1% | 0.6% | 0.7% | 0.8% | 0.6% | 0.9% | 0.8% | |
| 3.4% | 4.9% | 5.9% | 7.0% | 12.1% | 12.1% | 4.3% | 3.9% | 4.9% | 3.8% | 2.8% | 4.2% | |
| 0.0% | 0.0% | 0.0% | – | – | 50.4% | 23.6% | 25.6% | 28.3% | 20.1% | 6.8% | 4.8% | |
| 81.8% | 79.5% | 68.8% | 60.9% | 40.4% | 40.4% | 45.2% | 49.3% | 43.5% | 59.7% | 73.2% | 74.9% | |
| -61.8% | -28.1% | -13.5% | -38.4% | -62.3% | -62.3% | -75.0% | -86.0% | -111.9% | -55.9% | -34.6% | -12.5% | |
| 103.7% | 83.6% | 58.3% | 95.8% | 88.8% | 86.0% | 53.6% | 58.7% | 65.9% | 61.1% | 56.5% | 43.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.